Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-11
DOI
10.3389/fendo.2022.897776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children
- (2022) Amy S. Shah et al. Annual Review of Medicine
- Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
- (2022) William V Tamborlane et al. Lancet Diabetes & Endocrinology
- Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
- (2021) Jixue Tan et al. Frontiers in Pharmacology
- Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017
- (2021) Jean M. Lawrence et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Complications in Youth-Onset Type 2 Diabetes
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
- (2021) Muhammad Yazid Jalaludin et al. PEDIATRIC DIABETES
- A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
- (2021) R. Ravi Shankar et al. PEDIATRIC DIABETES
- Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
- (2020) Apostolos Tsapas et al. ANNALS OF INTERNAL MEDICINE
- Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes
- (2020) Jennifer Trujillo JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Network meta‐analysis of multicomponent interventions
- (2019) Gerta Rücker et al. BIOMETRICAL JOURNAL
- Liraglutide in Children and Adolescents with Type 2 Diabetes
- (2019) William V. Tamborlane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes in Youth—Looking Backwards to Inform the Future: Kelly West Award Lecture 2017
- (2018) Dana Dabelea DIABETES CARE
- Type 2 diabetes in adolescents and young adults
- (2018) Nadia Lascar et al. Lancet Diabetes & Endocrinology
- Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes
- (2017) William V Tamborlane et al. PEDIATRIC DIABETES
- Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
- (2017) Giuseppe Derosa et al. Drug Design Development and Therapy
- Ranking treatments in frequentist network meta-analysis works without resampling methods
- (2015) Gerta Rücker et al. BMC Medical Research Methodology
- Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2014) David J. Klein et al. Diabetes Technology & Therapeutics
- Liraglutide for the treatment of type 2 diabetes
- (2014) D Shyangdan et al. HEALTH TECHNOLOGY ASSESSMENT
- Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
- (2014) Dana Dabelea et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience
- (2013) DIABETES CARE
- Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
- (2012) M. Nauck et al. DIABETES OBESITY & METABOLISM
- Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
- (2012) J. P. T. Higgins et al. Research Synthesis Methods
- Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks
- (2011) A. Pfützner et al. DIABETES OBESITY & METABOLISM
- DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes
- (2011) Thomas Blevins et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
- (2011) Lei Chen et al. Nature Reviews Endocrinology
- Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, doubl
- (2010) W. Yang et al. DIABETES OBESITY & METABOLISM
- Checking consistency in mixed treatment comparison meta-analysis
- (2010) S. Dias et al. STATISTICS IN MEDICINE
- The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
- (2009) R. A. DeFronzo et al. DIABETES CARE
- Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
- (2009) P. Aschner et al. DIABETES OBESITY & METABOLISM
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started